Largest Biotechnology Companies by Market Cap
The Biotechnology sector has 1,250 publicly listed stocks with a combined market cap of $1.90 Trillion. Vertex Pharmaceuticals Inc leads the sector with a market cap of $107.56 Billion. This ranking covers all Biotechnology stocks globally — from large-cap industry leaders to mid-cap and small-cap companies — ranked by market capitalization and updated daily.
Total Market Cap (USD)
$1.90 Trillion
Companies Listed
1,250
Largest Company
Vertex Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
$107.56 Billion | $107.56 Billion | USA | $423.92 | -0.81% | -2.57% | 26.29 Million |
| 2 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
$72.88 Billion | $72.88 Billion | USA | $701.42 | -0.80% | -8.43% | 17.34 Million |
| 3 |
UCB SA
BR:UCB |
$51.45 Billion | €44.01 Billion | Belgium | €231.20 | +2.21% | -4.90% | 6.60 Million |
| 4 |
argenx NV ADR
NASDAQ:ARGX |
$45.97 Billion | $45.97 Billion | USA | $787.95 | -0.66% | -6.29% | 7.48 Million |
| 5 |
UCB S.A. UNSP.ADR 1/2
F:UNC0 |
$44.84 Billion | €38.35 Billion | Germany | €120.00 | -2.44% | -11.11% | 1.13K |
| 6 |
Argen-X
F:1AE |
$44.01 Billion | €37.64 Billion | Germany | €655.20 | +0.03% | -1.71% | 20.00 |
| 7 |
CSL Ltd
AU:CSL |
$42.85 Billion | AU$60.57 Billion | Australia | AU$124.84 | +0.38% | -3.22% | 33.41 Million |
| 8 |
Argen-X
BR:ARGX |
$42.08 Billion | €35.99 Billion | Belgium | €668.00 | +1.83% | -1.53% | 2.25 Million |
| 9 |
CSL LTD SPON.ADR 2
F:CSJA |
$40.06 Billion | €34.26 Billion | Germany | €18.20 | -3.19% | -9.90% | 420.00 |
| 10 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
$39.27 Billion | $39.27 Billion | USA | $296.11 | -4.32% | -5.63% | 26.10 Million |
| 11 |
Samsung Biologics Co Ltd
KO:207940 |
$31.37 Billion | ₩46.29 Trillion | Korea | ₩1000000.00 | +0.00% | +0.00% | 1.25 Million |
| 12 |
BeiGene, Ltd.
NASDAQ:ONC |
$30.02 Billion | $30.02 Billion | USA | $293.86 | -0.48% | -1.98% | 4.74 Million |
| 13 |
Celltrion Inc
KO:068270 |
$29.73 Billion | ₩43.86 Trillion | Korea | ₩200500.00 | -1.72% | -1.72% | 10.93 Million |
| 14 |
Insmed Inc
NASDAQ:INSM |
$28.42 Billion | $28.42 Billion | USA | $133.26 | -2.25% | -7.35% | 47.15 Million |
| 15 |
BeiGene Ltd.
F:49B |
$25.73 Billion | €22.01 Billion | Germany | €17.34 | +4.43% | +6.10% | 5.38K |
| 16 |
BioNTech SE
F:22UA |
$23.24 Billion | €19.88 Billion | Germany | €88.25 | +3.22% | -5.92% | 6.55K |
| 17 |
Royalty Pharma Plc
NASDAQ:RPRX |
$21.19 Billion | $21.19 Billion | USA | $49.47 | -1.24% | -0.34% | 64.93 Million |
| 18 |
Roivant Sciences Ltd
NASDAQ:ROIV |
$19.92 Billion | $19.92 Billion | USA | $27.83 | -2.45% | -1.10% | 112.92 Million |
| 19 |
Incyte Corporation
NASDAQ:INCY |
$19.29 Billion | $19.29 Billion | USA | $96.91 | +1.72% | +1.51% | 33.54 Million |
| 20 |
Revolution Medicines Inc
NASDAQ:RVMD |
$18.62 Billion | $18.62 Billion | USA | $139.48 | -3.22% | +3.72% | 94.58 Million |
| 21 |
Moderna Inc
NASDAQ:MRNA |
$17.99 Billion | $17.99 Billion | USA | $45.37 | -1.24% | -14.15% | 138.74 Million |
| 22 |
Innovent Biologics Inc
F:6IB |
$16.50 Billion | €14.11 Billion | Germany | €9.80 | +7.40% | +0.99% | 4.33K |
| 23 |
Genmab A/S
CO:GMAB |
$16.33 Billion | Dkr104.35 Billion | Denmark | Dkr1694.00 | +0.24% | -2.84% | 2.72 Million |
| 24 |
Genmab AS
NASDAQ:GMAB |
$16.24 Billion | $16.24 Billion | USA | $26.45 | -0.26% | -1.96% | 36.24 Million |
| 25 |
GENMAB AS SP.ADR/1/10DK 1
F:GE91 |
$15.06 Billion | €12.88 Billion | Germany | €23.80 | +3.48% | -2.46% | 68.00 |
| 26 |
WUXI BIOLOGICS UNSP.ADR/2
F:1FW1 |
$14.75 Billion | €12.62 Billion | Germany | €7.20 | -2.04% | -9.43% | 42.00K |
| 27 |
WUXI BIOLOGICS-00000083
F:1FW2 |
$14.60 Billion | €12.49 Billion | Germany | €3.58 | -1.65% | -4.79% | 11.10K |
| 28 |
Ascendis Pharma AS
NASDAQ:ASND |
$13.56 Billion | $13.56 Billion | USA | $220.93 | -3.68% | -1.81% | 17.92 Million |
| 29 |
ALTEOGEN Inc
KQ:196170 |
$13.36 Billion | ₩19.71 Trillion | Korea | ₩368500.00 | -3.03% | +2.50% | 6.74 Million |
| 30 |
Ascendis Pharma AS
F:A71 |
$13.23 Billion | €11.31 Billion | Germany | €206.00 | +0.98% | +4.04% | 166.00 |
| 31 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
$13.14 Billion | $13.14 Billion | USA | $68.56 | -3.59% | -4.34% | 56.43 Million |
| 32 |
AKESO INC. O.N.
F:4RY |
$12.38 Billion | €10.59 Billion | Germany | €14.93 | +1.39% | -5.21% | 3.78K |
| 33 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
$12.20 Billion | $12.20 Billion | USA | $202.72 | -0.15% | +1.38% | 20.57 Million |
| 34 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
$12.19 Billion | $12.19 Billion | USA | $75.28 | +0.70% | +1.61% | 42.17 Million |
| 35 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
$11.90 Billion | $11.90 Billion | USA | $518.74 | -1.97% | +0.03% | 8.60 Million |
| 36 |
Exelixis Inc
NASDAQ:EXEL |
$11.34 Billion | $11.34 Billion | USA | $43.68 | -1.75% | -5.15% | 54.70 Million |
| 37 |
Summit Therapeutics PLC
NASDAQ:SMMT |
$11.14 Billion | $11.14 Billion | USA | $16.12 | -24.91% | -27.64% | 104.39 Million |
| 38 |
Avidity Biosciences, Inc
NASDAQ:RNAM |
$11.02 Billion | $11.02 Billion | USA | $71.34 | +0.00% | +0.00% | 0.00 |
| 39 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
$10.40 Billion | $10.40 Billion | USA | $54.06 | +0.28% | +0.15% | 35.99 Million |
| 40 |
Tubize-Fin
BR:TUB |
$9.89 Billion | €8.46 Billion | Belgium | €195.70 | +2.19% | -6.36% | 597.84K |
| 41 |
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
$9.59 Billion | CN¥65.55 Billion | China | CN¥58.53 | +5.40% | +0.24% | 153.21 Million |
| 42 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
$9.33 Billion | $9.33 Billion | USA | $117.61 | +0.20% | +4.08% | 20.01 Million |
| 43 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
$9.19 Billion | $9.19 Billion | USA | $74.81 | +1.81% | +0.55% | 40.59 Million |
| 44 |
Verona Pharma plc
F:I9SA |
$9.07 Billion | €7.76 Billion | Germany | €90.20 | +0.67% | +0.22% | 2.25K |
| 45 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
$8.92 Billion | $8.92 Billion | USA | $324.20 | +1.68% | -1.64% | 9.11 Million |
| 46 |
Jazz Pharmaceuticals plc
F:J7Z |
$8.86 Billion | €7.58 Billion | Germany | €172.35 | +0.73% | -0.03% | 52.00 |
| 47 |
Bio-Techne Corp
NASDAQ:TECH |
$8.61 Billion | $8.61 Billion | USA | $55.02 | -0.54% | +5.40% | 47.01 Million |
| 48 |
Blueprint Medicines Corp
NASDAQ:BPMC |
$8.36 Billion | $8.36 Billion | USA | $129.46 | +0.14% | +0.71% | 107.21 Million |
| 49 |
Vaxcyte Inc
NASDAQ:PCVX |
$8.19 Billion | $8.19 Billion | USA | $56.93 | -0.54% | -6.32% | 27.24 Million |
| 50 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
$7.88 Billion | $7.88 Billion | USA | $206.53 | -0.59% | +13.03% | 16.57 Million |
| 51 |
Krystal Biotech Inc
NASDAQ:KRYS |
$7.71 Billion | $7.71 Billion | USA | $266.04 | +1.44% | -0.75% | 5.92 Million |
| 52 |
ALK-Abelló A/S
CO:ALK-B |
$7.62 Billion | Dkr48.72 Billion | Denmark | Dkr242.00 | +1.51% | +7.46% | 5.39 Million |
| 53 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
$7.52 Billion | $7.52 Billion | USA | $63.96 | +0.47% | -3.95% | 31.96 Million |
| 54 |
Cytokinetics Inc
NASDAQ:CYTK |
$7.39 Billion | $7.39 Billion | USA | $63.35 | -0.97% | -3.25% | 39.59 Million |
| 55 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
$7.31 Billion | $7.31 Billion | USA | $86.00 | +0.00% | -2.27% | 31.77 Million |
| 56 |
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SHG:603392 |
$7.27 Billion | CN¥49.69 Billion | China | CN¥39.30 | +0.59% | +0.98% | 77.19 Million |
| 57 |
Abivax SA
PA:ABVX |
$6.97 Billion | €5.96 Billion | France | €96.45 | +3.16% | -2.72% | 2.72 Million |
| 58 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
$6.96 Billion | $6.96 Billion | USA | $221.38 | +0.03% | +0.26% | 24.25 Million |
| 59 |
Merus BV
NASDAQ:MRUS |
$6.83 Billion | $6.83 Billion | USA | $90.00 | -7.14% | -7.02% | 27.33 Million |
| 60 |
Nuvalent Inc
NASDAQ:NUVL |
$6.66 Billion | $6.66 Billion | USA | $99.04 | -1.24% | -8.31% | 14.56 Million |
| 61 |
Pharmaron Beijing Co Ltd
SHE:300759 |
$6.33 Billion | CN¥43.28 Billion | China | CN¥29.31 | -1.48% | -3.71% | 958.10 Million |
| 62 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
$6.32 Billion | $6.32 Billion | USA | $80.71 | -0.44% | -7.41% | 12.95 Million |
| 63 |
Belite Bio Inc ADR
NASDAQ:BLTE |
$6.17 Billion | $6.17 Billion | USA | $164.45 | -1.77% | -2.55% | 3.65 Million |
| 64 |
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
$6.12 Billion | CN¥41.82 Billion | China | CN¥125.56 | -0.98% | +11.08% | 283.26 Million |
| 65 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
$6.10 Billion | $6.10 Billion | USA | $39.43 | -0.10% | -0.45% | 113.44 Million |
| 66 |
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
$6.10 Billion | CN¥41.67 Billion | China | CN¥92.60 | -1.04% | -5.31% | 127.61 Million |
| 67 |
Immunitybio Inc
NASDAQ:IBRX |
$5.96 Billion | $5.96 Billion | USA | $7.11 | +0.14% | -13.19% | 344.24 Million |
| 68 |
3SBio Inc
F:83B |
$5.88 Billion | €5.03 Billion | Germany | €2.46 | +5.11% | -5.46% | 17.98K |
| 69 |
Cogent Biosciences Inc
NASDAQ:COGT |
$5.86 Billion | $5.86 Billion | USA | $36.63 | +2.35% | +1.36% | 51.78 Million |
| 70 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
$5.82 Billion | $5.82 Billion | USA | $96.53 | -0.80% | +4.98% | 15.53 Million |
| 71 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
$5.60 Billion | $5.60 Billion | USA | $66.27 | -0.70% | -5.18% | 25.51 Million |
| 72 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
$5.59 Billion | $5.59 Billion | USA | $81.81 | +0.55% | -3.99% | 15.46 Million |
| 73 |
Hebei Changshan Biochem Pharma
SHE:300255 |
$5.56 Billion | CN¥38.01 Billion | China | CN¥41.36 | +0.34% | -0.48% | 616.83 Million |
| 74 |
HLB Co. Ltd
KQ:028300 |
$5.41 Billion | ₩7.98 Trillion | Korea | ₩60800.00 | -3.49% | +0.33% | 18.82 Million |
| 75 |
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
$5.40 Billion | CN¥36.91 Billion | China | CN¥5.56 | +0.18% | -1.24% | 645.11 Million |
| 76 |
PTC Therapeutics Inc
NASDAQ:PTCT |
$5.39 Billion | $5.39 Billion | USA | $65.15 | +0.14% | -5.02% | 23.95 Million |
| 77 |
Chongqing Zhifei Bio Products
SHE:300122 |
$5.31 Billion | CN¥36.27 Billion | China | CN¥15.15 | +0.66% | -0.85% | 446.29 Million |
| 78 |
Sk Biopharmaceuticals Co Ltd
KO:326030 |
$5.30 Billion | ₩7.82 Trillion | Korea | ₩99900.00 | -1.87% | -3.48% | 4.26 Million |
| 79 |
Immunovant Inc
NASDAQ:IMVT |
$5.24 Billion | $5.24 Billion | USA | $27.12 | -0.09% | -6.19% | 37.29 Million |
| 80 |
Apellis Pharmaceuticals Inc
NASDAQ:APLS |
$5.20 Billion | $5.20 Billion | USA | $40.96 | +0.02% | +0.05% | 210.97 Million |
| 81 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
$5.09 Billion | $5.09 Billion | USA | $98.37 | -0.61% | -4.14% | 15.86 Million |
| 82 |
ABL Bio Inc
KQ:298380 |
$5.04 Billion | ₩7.43 Trillion | Korea | ₩134800.00 | -5.07% | -10.37% | 13.33 Million |
| 83 |
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI |
$5.00 Billion | $5.00 Billion | USA | $18.47 | -2.79% | -6.67% | 43.45 Million |
| 84 |
Crispr Therapeutics AG
NASDAQ:CRSP |
$4.96 Billion | $4.96 Billion | USA | $51.63 | -1.36% | -6.43% | 40.20 Million |
| 85 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
$4.93 Billion | $4.93 Billion | USA | $80.75 | -2.58% | -8.54% | 15.43 Million |
| 86 |
Celcuity LLC
NASDAQ:CELC |
$4.84 Billion | $4.84 Billion | USA | $125.65 | +3.54% | +10.65% | 18.09 Million |
| 87 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
$4.69 Billion | $4.69 Billion | USA | $46.37 | -0.51% | -2.34% | 37.62 Million |
| 88 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
$4.63 Billion | $4.63 Billion | USA | $87.42 | -0.43% | -2.67% | 16.37 Million |
| 89 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
$4.54 Billion | $4.54 Billion | USA | $14.49 | +0.00% | +0.21% | 59.70 Million |
| 90 |
CENTESSA PHARMACEUTICALS
F:260 |
$4.54 Billion | €3.88 Billion | Germany | €33.20 | +1.84% | +0.61% | 590.00 |
| 91 |
LegoChem Biosciences Inc
KQ:141080 |
$4.52 Billion | ₩6.68 Trillion | Korea | ₩183400.00 | -5.71% | -2.60% | 9.47 Million |
| 92 |
TG Therapeutics Inc
NASDAQ:TGTX |
$4.52 Billion | $4.52 Billion | USA | $33.85 | +0.21% | -8.32% | 42.72 Million |
| 93 |
Shanghai Junshi Biosciences Co Ltd
SHG:688180 |
$4.52 Billion | CN¥30.91 Billion | China | CN¥40.38 | +0.20% | -4.70% | 562.02 Million |
| 94 |
Akero Therapeutics Inc
NASDAQ:AKRO |
$4.50 Billion | $4.50 Billion | USA | $54.65 | +0.00% | +0.39% | 64.49 Million |
| 95 |
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
$4.13 Billion | CN¥28.20 Billion | China | CN¥14.26 | -1.31% | -4.87% | 219.36 Million |
| 96 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
$4.12 Billion | $4.12 Billion | USA | $70.50 | +0.00% | -13.55% | 97.45 Million |
| 97 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
$4.11 Billion | $4.11 Billion | USA | $52.93 | +0.00% | +0.19% | 164.07 Million |
| 98 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
$4.09 Billion | $4.09 Billion | USA | $39.02 | +0.62% | +1.32% | 25.11 Million |
| 99 |
Arcellx Inc
NASDAQ:ACLX |
$4.04 Billion | $4.04 Billion | USA | $115.07 | +0.00% | +0.08% | 32.09 Million |
| 100 |
Suzhou Zelgen Biopharmaceuticals Co Ltd
SHG:688266 |
$4.03 Billion | CN¥27.53 Billion | China | CN¥104.00 | +3.59% | +2.79% | 89.49 Million |
| 101 |
BrightGene Bio Medical Technology C
SHG:688166 |
$3.91 Billion | CN¥26.70 Billion | China | CN¥63.10 | +6.77% | +11.17% | 374.10 Million |
| 102 |
Hualan Biological EngineeringInc
SHE:002007 |
$3.86 Billion | CN¥26.35 Billion | China | CN¥14.42 | -0.83% | -3.16% | 208.29 Million |
| 103 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
$3.74 Billion | $3.74 Billion | USA | $21.95 | -2.23% | -0.72% | 40.24 Million |
| 104 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
$3.62 Billion | $3.62 Billion | USA | $227.44 | -0.88% | -0.46% | 5.09 Million |
| 105 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
$3.54 Billion | $3.54 Billion | USA | $46.99 | +0.02% | +0.06% | 111.23 Million |
| 106 |
Xiamen Amoytop Biotech Co Ltd
SHG:688278 |
$3.48 Billion | CN¥23.78 Billion | China | CN¥58.25 | -1.85% | -7.58% | 68.57 Million |
| 107 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
$3.42 Billion | $3.42 Billion | USA | $51.42 | +10.53% | +14.06% | 28.51 Million |
| 108 |
Camurus AB
ST:CAMX |
$3.41 Billion | Skr31.67 Billion | Sweden | Skr531.00 | +0.38% | -6.60% | 1.95 Million |
| 109 |
Zealand Pharma A/S
CO:ZEAL |
$3.41 Billion | Dkr21.77 Billion | Denmark | Dkr309.00 | +3.21% | +1.21% | 8.05 Million |
| 110 |
Viking Therapeutics Inc
NASDAQ:VKTX |
$3.35 Billion | $3.35 Billion | USA | $30.00 | -3.78% | -8.54% | 57.24 Million |
| 111 |
Liquidia Technologies Inc
NASDAQ:LQDA |
$3.32 Billion | $3.32 Billion | USA | $38.14 | -2.73% | +1.82% | 24.30 Million |
| 112 |
TELIX Pharmaceuticals Ltd
AU:TLX |
$3.27 Billion | AU$4.62 Billion | Australia | AU$15.57 | +3.80% | +7.90% | 68.27 Million |
| 113 |
Legend Biotech Corp
NASDAQ:LEGN |
$3.25 Billion | $3.25 Billion | USA | $23.59 | +0.30% | -1.67% | 51.28 Million |
| 114 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
$3.24 Billion | $3.24 Billion | USA | $56.13 | +0.16% | +1.30% | 22.72 Million |
| 115 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
$3.24 Billion | $3.24 Billion | USA | $30.61 | -1.13% | -1.99% | 22.12 Million |
| 116 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
$3.22 Billion | $3.22 Billion | USA | $28.43 | -0.46% | -9.63% | 21.99 Million |
| 117 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
$3.15 Billion | $3.15 Billion | USA | $28.74 | +2.17% | +3.83% | 42.37 Million |
| 118 |
Dashenlin Pharm Grp Co Ltd
SHG:603233 |
$3.12 Billion | CN¥21.32 Billion | China | CN¥18.72 | -3.26% | +5.23% | 134.85 Million |
| 119 |
Erasca Inc
NASDAQ:ERAS |
$3.12 Billion | $3.12 Billion | USA | $10.03 | -5.82% | -55.36% | 221.24 Million |
| 120 |
Genscript Biotech Corporation
F:G51 |
$3.01 Billion | €2.58 Billion | Germany | €1.47 | +0.68% | -7.55% | 2.40K |
| 121 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
$2.99 Billion | $2.99 Billion | USA | $42.21 | +1.83% | -10.23% | 23.63 Million |
| 122 |
Alumis Inc
NASDAQ:ALMS |
$2.92 Billion | $2.92 Billion | USA | $25.18 | +1.98% | -3.12% | 35.37 Million |
| 123 |
Travere Therapeutics Inc
NASDAQ:TVTX |
$2.90 Billion | $2.90 Billion | USA | $44.12 | +4.75% | +8.08% | 58.92 Million |
| 124 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
$2.90 Billion | $2.90 Billion | USA | $23.35 | +0.56% | +2.14% | 25.08 Million |
| 125 |
Dyne Therapeutics Inc
NASDAQ:DYN |
$2.87 Billion | $2.87 Billion | USA | $17.39 | -0.91% | -7.99% | 40.38 Million |
| 126 |
Denali Therapeutics Inc
NASDAQ:DNLI |
$2.86 Billion | $2.86 Billion | USA | $18.30 | -2.24% | -5.91% | 34.92 Million |
| 127 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
$2.84 Billion | $2.84 Billion | USA | $69.42 | -6.76% | +0.26% | 32.10 Million |
| 128 |
Soleno Therapeutics Inc
NASDAQ:SLNO |
$2.72 Billion | $2.72 Billion | USA | $52.87 | +0.09% | +0.08% | 147.22 Million |
| 129 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
$2.69 Billion | $2.69 Billion | USA | $63.62 | +0.02% | +4.35% | 12.01 Million |
| 130 |
Sinocelltech Group Ltd
SHG:688520 |
$2.68 Billion | CN¥18.34 Billion | China | CN¥41.18 | -0.39% | -3.94% | 92.62 Million |
| 131 |
Beam Therapeutics Inc
NASDAQ:BEAM |
$2.66 Billion | $2.66 Billion | USA | $30.70 | +1.22% | +1.79% | 50.67 Million |
| 132 |
Kodiak Sciences Inc
NASDAQ:KOD |
$2.62 Billion | $2.62 Billion | USA | $43.96 | +1.10% | -2.76% | 23.60 Million |
| 133 |
BioArctic AB (publ)
ST:BIOA-B |
$2.59 Billion | Skr24.04 Billion | Sweden | Skr323.80 | +1.76% | +0.68% | 5.06 Million |
| 134 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
$2.54 Billion | $2.54 Billion | USA | $32.31 | -1.73% | -3.70% | 25.47 Million |
| 135 |
ADMA Biologics Inc
NASDAQ:ADMA |
$2.51 Billion | $2.51 Billion | USA | $10.52 | +2.63% | -5.05% | 137.22 Million |
| 136 |
Vera Therapeutics Inc
NASDAQ:VERA |
$2.50 Billion | $2.50 Billion | USA | $35.20 | -1.15% | -8.31% | 28.25 Million |
| 137 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
$2.47 Billion | $2.47 Billion | USA | $28.19 | -3.13% | -8.18% | 37.93 Million |
| 138 |
Arcus Biosciences Inc
NYSE:RCUS |
$2.38 Billion | $2.38 Billion | USA | $25.68 | +0.71% | +2.19% | 27.74 Million |
| 139 |
Jinyu Bio-Technology Co Ltd
SHG:600201 |
$2.37 Billion | CN¥16.22 Billion | China | CN¥14.59 | +3.99% | +2.03% | 541.79 Million |
| 140 |
Immunome Inc
NASDAQ:IMNM |
$2.35 Billion | $2.35 Billion | USA | $22.73 | -0.92% | -1.13% | 25.98 Million |
| 141 |
OliX PharmaceuticalsInc
KQ:226950 |
$2.35 Billion | ₩3.47 Trillion | Korea | ₩172500.00 | -6.55% | +3.85% | 6.90 Million |
| 142 |
Bavarian Nordic
CO:BAVA |
$2.30 Billion | Dkr14.71 Billion | Denmark | Dkr188.00 | +0.43% | +0.05% | 5.30 Million |
| 143 |
SK Bioscience Co Ltd
KO:302440 |
$2.29 Billion | ₩3.38 Trillion | Korea | ₩43050.00 | -1.37% | -1.82% | 2.57 Million |
| 144 |
BB Biotech AG
SW:BION |
$2.25 Billion | CHF1.78 Billion | Switzerland | CHF44.15 | -0.79% | -3.71% | 1.95 Million |
| 145 |
Zai Lab Ltd
NASDAQ:ZLAB |
$2.24 Billion | $2.24 Billion | USA | $21.54 | -0.46% | -1.55% | 17.76 Million |
| 146 |
Chengzhi Shareholding Co Ltd
SHE:000990 |
$2.24 Billion | CN¥15.31 Billion | China | CN¥12.60 | -2.63% | +5.53% | 1.97 Billion |
| 147 |
Pharma Reaserch Prod Co Ltd
KQ:214450 |
$2.21 Billion | ₩3.26 Trillion | Korea | ₩313500.00 | -2.64% | +3.29% | 1.64 Million |
| 148 |
89bio Inc
NASDAQ:ETNB |
$2.20 Billion | $2.20 Billion | USA | $14.84 | +0.00% | +0.27% | 140.50 Million |
| 149 |
Adaptive Biotechnologies Corp
NASDAQ:ADPT |
$2.19 Billion | $2.19 Billion | USA | $14.27 | +1.21% | +3.26% | 37.03 Million |
| 150 |
Anhui Anke BioTech Group
SHE:300009 |
$2.16 Billion | CN¥14.77 Billion | China | CN¥8.84 | -1.23% | -9.80% | 539.41 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries